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We have previously shown that, assuming urea distribution
volume (V) remains constant for 1 month, ionic dialysance
(ID) allows the dialysis dose to be calculated without the
need for blood sampling. The aim of this multicenter study
was to verify whether the assumption of a constant V can be
extended to 1 year. In clinically stable patients receiving
thrice-weekly hemodialysis at 13 dialysis centers, V and Kt/V
were assessed during three dialysis sessions at baseline and 1
year later using ID as dialyzer urea clearance and the
single-pool urea kinetic model. Baseline albumin,
hemoglobin, and C reactive protein were prespecified
covariates for predicting the change in V over time. Of the 52
enrolled patients, 40 (25 males; age 63.0713.5 years)
completed the study. Baseline end-dialysis body weight
(62.4713.7 kg) showed a non-significant 1% reduction
during follow-up (0.672.8 kg; P¼ 0.175), whereas V
significantly decreased from 29.076.8 to 27.476.0 l
(1.673.0 l or 4.5%; P¼ 0.002). The reduction in V was
greater when baseline albumin was lower (P¼ 0.001) and
baseline V was higher (P¼ 0.005). The single-pool Kt/V
calculated using baseline V underestimated the actual value
by 0.0770.16 (P¼ 0.008). The slight underestimate of Kt/V
during follow-up suggests that annual V evaluations may be
sufficient for dialysis dose quantification as the only risk is
underestimating the actually delivered dialysis dose.
However, the relationship between baseline albumin and the
reduction in V over time may have nutritional value, and
suggests more frequent V evaluations.
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Assessing the delivered dialysis dose (expressed as Kt/V) is
particularly relevant because of its relationship to morbidity
and mortality.1–4 Kt/V is usually determined by means of the
single-pool, variable-volume urea kinetic model, which
requires the taking of blood samples to determine urea
concentrations at the start and end of each dialysis session.5
As urea transfer from one body compartment to another is
not instantaneous, and in order to avoid a significant
overestimate of Kt/V, the post-dialysis blood sample used
for urea analysis is usually drawn 30 min after the end of the
session (eqKt/V), when post-dialysis urea rebound is
exhausted.6 The alternative methods proposed by Smye
et al.7 and Daugirdas and Schneditz8 obviate the problem of
delayed post-dialysis blood sampling, but they also requires
two or three blood samples. The result is that the delivered
dialysis dose is quantified infrequently, and current inter-
national National Kidney Foundation Kidney Disease
Outcomes Quality Initiative and European Best Practice
Guidelines9,10 recommend checking it at monthly intervals
(a pragmatic rather than ideal recommendation).
On the other hand, a number of factors can lead to a lower
than prescribed delivered dialysis dose,11,12 and some data
suggest that there may be considerable variations in dose
delivery between one session and another.13,14 Consequently,
more frequent measurements may be desirable. When using
the single-pool, variable volume urea kinetic model, the
calculation of Kt/V is based on solution for urea distribution
volume (V) at the end of dialysis session. Once an average
mean V value has been established for an individual patient,
the delivered Kt/V could be monitored at every dialysis
session by determining dialyzer urea clearance (K) and
treatment time (Td), because it seems reasonable to assume
that V remains constant for prolonged periods of time in
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stable patients and only needs to be corrected for the
difference in final body weight between one dialysis session
and another.
The availability of online measurements of ionic dia-
lysance (ID) may offer a step towards monitoring dialysis at
each session.15,16 It has been shown that instantaneous
effective ID can be measured without the need for any blood
or dialysate sampling simply by using two conductivity
probes placed at the dialyzer inlet and outlet.17,18 This allows
repeated measurements of ID that can be used to obtain the
mean value for the dialysis session as a whole.
In a previous study,19 we showed that, once V has been
determined, the use of ID makes it possible to calculate Kt/V
at each dialysis session without the need for blood sampling
for at least 1 month.
This prospective multicenter study was planned in order
to determine whether the assumption of a constant V in
stable hemodialysis patients can be extended to such a long
period as 1 year, and the extent of the bias of the Kt/V
calculations considering V as constant.
RESULTS
General
Forty of the 52 patients recruited in the 13 Italian dialysis
centers completed the planned 1-year follow-up: the 12
patients (23%) who dropped out earlier did so because of
renal transplantation (one patient), transfer to another center
(one), transfer to a dialytic run without the Integra machine
and the Diascan module (one), vascular access thrombosis
(one), leg amputation (one), myocardial infarction (one), the
placement of a single-lumen central venous catheter (one),
sepsis (one), hepatic coma (one), missing data concerning
key relevant variables (one), and consent withdrawal (two).
The baseline characteristics of the 40 evaluated patients
(25 males, 63%) are shown in Table 1. They had a mean age
of 63 years, a median dialysis vintage of 3.8 years, a mean
dialysis time of 232 min per session and a mean end-dialysis
body weight of 62.4 kg. Both types of dialysis membrane
(cellulose, 22 patients; synthetic, 18) were used with a median
dialysis surface area of 1.6 m2 throughout the study. The
mean blood flow rate was 318 ml/min and the dialysate flow
rate was 500 ml/min. Thirty-four patients (85%) were
dialyzed using a distal native fistula and six (15%) using a
proximal native fistula.
Changes after 1 year
The within-patient variability in eqV and non-eqV, estimated by
standard deviation, was 2.2971.44 and 2.2772.20 l at
baseline, and 2.2271.57 and 2.0971.97 l after 1 year, with
a mean difference of 0.0771.61 and 0.1973.00 l (P¼ 0.784
and 0.697). The overall within-patient variability was there-
fore relevant, being 2.2671.50 and 2.1872.07 l (for eqV and
non-eqV, respectively) over the entire follow-up.
The dialytic parameters and laboratory values at baseline
and after 1 year are shown in Table 2. As expected in the
study protocol, blood flow rate, dialysis duration, and
equilibrated and non-equilibrated Kt/V remained constant
during the follow-up; on the contrary, end-dialysis body
weight, mean ID, and urea distribution volume decreased.
Although the mean reduction in end-dialysis body weight at
the end of the follow-up was only 0.672.8 kg and not
significant (P¼ 0.175), eqV calculated by means of the
equilibrated post-dialysis sample (Ct300) decreased by
1.9272.91 l (Po0.001). When the reduction in eqV was
adjusted for the reduction in end-dialysis body weight, it was
1.3173.67 l and the difference from baseline remained
significant (P¼ 0.03).
The reduction in urea distribution volume after 1 year
varied widely, as can be seen by the high standard deviations
around the mean values of 2.91 for eqV and 2.99 l for non-eqV.
There was a direct and significant relationship between the
decreases in V and ID using both eqV and non-eqV values. The
Table 1 | Baseline clinical and laboratory characteristics of the
study patients
No. of patients 40
Age (years) 63.0713.5
Pre-dialysis body weight (kg) 64.9714.0
End-dialysis body weight (kg) 62.4713.7
Gender
Male 25 (63)
Female 15 (37)
Renal disease
Diabetes 4 (10)
Polycystic kidney disease 5 (12)
Glomerulonephritis 6 (15)
Nephroangiosclerosis 5 (12)
Other 20 (50)
Vascular access
Native distal fistula 34 (85)
Native proximal fistula 6 (15)
Dialysis duration (min) 232721
Dialysis vintage (years) 3.8 (1.9–7.7)
Pre-dialysis plasma urea concentration (mg/dl) 185.8768.7
Non-equilibrated post-dialysis plasma urea
concentration (mg/dl)a
55.3723.7
Equilibrated post-dialysis plasma urea
concentration (mg/dl)b
65.3725.7
eqKt/V 1.2870.21
eqnPCR (g/kg/day) 0.9870.27
Albumin (g/dl) 3.9870.34
C reactive protein (mg/l) 3.8 (2.8–10.0)
Hematocrit (%) 33.173.4
Blood flow rate (ml/min) 318732
Dialysate flow rate (ml/min) 500
Ionic dialysance (ml/min) 182716
Dialyser membrane
Cellulose 22 (55)
Synthetic 18 (45)
Filter surface area (m2) 1.6 (1.5–1.8)
Arithmetic mean values7s.d. for continuous normally distributed variables; median
values and interquartile ranges for continuous non-normally distributed variables;
and counts and percentages for categorical variables.
aBlood samples drawn 10 s after the end of session.
bBlood samples taken 30 min after the end of session.
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adjusted R2 values of the two linear models were, respectively,
0.09 (P¼ 0.029) and 0.13 (P¼ 0.013).
Accordingly, at the end of the follow-up, the eqKt/V value
estimated using baseline V values was significantly lower than
the up-dated value: the mean difference was 0.0770.11, an
underestimate of 5.3% (Po0.001). Likewise, the V calculated
using the post-dialysis non-equilibrated sample (Ct1000)
significantly decreased by 1.5672.99 l (P¼ 0.002) but, after
adjustment for the reduction in final body weight, it was
0.9574.30 l and no longer statistically significant (P¼ 0.172).
However, the magnitude of the 1-year underestimate of non-
equilibrated Kt/V using the V determined at baseline (instead
of the up-dated V) was the same (0.07), with a small
increase in variability (a standard deviation of 0.16 vs 0.11).
Moreover, the difference between baseline spKt/V and eqKt/V
was 0.2370.09 and, as expected, did not change during the
follow-up (P¼ 0.670).
Predictors of the reduction in urea distribution volume
Multiple linear regression using a backward selection strategy
showed that the only predictors related to the change in
non-eqV after 1 year (Table 3) were baseline albumin levels
(P¼ 0.032) and baseline V values (P¼ 0.004): low baseline
albumin and high baseline V levels were associated with a
greater reduction in V over time. This simple two-predictor
model has a consistent predictive power (adjusted R2¼ 0.40).
When the dependent variable of the model was changed from
the change in non-eqV to the change in eqV, the predictors
remained the same (data not shown).
Simple linear regression showed a significant inverse
correlation between V values and patient age (B coefficient
0.313; R2¼ 0.21; P¼ 0.003) (Figure 1), but this explained
only 20% of the total reduction in V after 1-year follow-up.
Table 2 | Variations in body weight, urea distribution volume, and other patient and dialysis variables after 1 year of follow-up
Baseline 12 months Change P-value
Pre-dialysis body weight (kg) 64.9714.0 64.3714.5 0.673.1 0.211
End-dialysis body weight (kg) 62.4713.7 61.7714.1 0.672.8 0.175
Net ultrafiltration (kg/session) 2.670.7 2.670.6 070.6 0.976
Dialysis duration (min) 232721 233720 179 0.723
Ionic dialysance (ml/min) 182716 176714 6714 0.011
Blood flow rate (ml/min) 318732 319729 1721 0.849
Kinetic parameters (blood samples taken 30 min after the end of session)
Urea distribution volume (l) 33.9477.20 32.0276.47 1.9272.91 o0.001
Urea distribution volume (% of end-dialysis body weight) 55.177.5 52.877.9 2.374.5 0.002
Percent reduction in urea distribution volume (%) 5.178.2 o0.001
nPCR (g/kg/day) 0.9870.27 1.0570.28 0.0770.31 0.142
Urea reduction ratio 0.6570.06 0.6670.05 0.0170.04 0.211
Kt/V with updated urea distribution volume 1.2870.21 1.3170.2 0.0370.13 0.163
Kt/V using baseline urea distribution volume 1.2870.21 1.2470.2 0.0470.10 0.021
Kt/V underestimate using baseline urea distribution volume 0.0770.11 o0.001
Kinetic parameters (blood samples taken 10 s after the end of session)
Urea distribution volume (l) 28.9776.75 27.4176.03 1.5672.99 0.002
Urea distribution volume (% of end-dialysis body weight) 46.977.1 45.076.7 1.975.0 0.023
Percent reduction in urea distribution volume (%) 4.579.9 0.006
nPCR (g/kg/day) 1.0770.3 1.1670.31 0.0870.34 0.130
Urea reduction ratio 0.7070.06 0.7170.05 0.0170.04 0.300
Kt/V with updated urea distribution volume 1.5170.27 1.5370.22 0.0270.17 0.377
Kt/V using baseline urea distribution volume 1.5170.27 1.4670.27 0.0570.12 0.022
Kt/V underestimation using baseline urea distribution volume 0.0770.16 0.008
Difference between equilibrated and non-equilibrated urea distribution volume (l) 4.9771.57 4.6171.85 0.3672.18 0.301
Difference between equilibrated and non-equilibrated urea distribution volume (%) 8.272.7 7.773.1 0.573.3 0.377
Difference between single pool and equilibrated Kt/V 0.2370.09 0.2270.09 0.0170.10 0.670
Table 3 | Predictive variables at baseline related to urea
distribution volume change after 12 months’ follow-up
Dependent variable: urea
distribution volume change
95% CI of B
after 12 months’ follow-up (l) B Lower Upper P-value
Included variables
Albumin (g/dl) 1.120 0.103 2.137 0.032
Urea distribution volume (l) 0.210 0.346 0.074 0.004
Excluded variables
Age at baseline (years) 0.016 0.068 0.100 0.698
Gender (female vs male) 0.703 3.758 2.353 0.635
Dialysis vintage (years) 0.128 0.172 0.428 0.381
Dialysis treatment time (min) 0.042 0.053 0.137 0.365
Urea reduction ratio (%) 0.11 0.41 0.20 0.467
Protein catabolic rate (g/kg/die) 2.854 8.012 2.303 0.260
Hematocrit (%) 0.341 0.873 0.192 0.195
C reactive protein (mg/l) 0.95 5.82 7.73 0.771
Adjusted R2 of the model=0.40; B=regression coefficient; CI=confidence intervals.
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Moreover, there is a weak and not significant direct
correlation between serum albumin levels and urea distribu-
tion volume at baseline (B coefficient 0.012, R2¼ 0.07;
P¼ 0.105) (Figure 2).
DISCUSSION
The relevant information coming from the results of this
multicenter study can be summarized as follows: (a)
equilibrated and non-equilibrated urea distribution volume
decreases over time in clinically hemodialysis stable patients;
(b) in depuration terms, the slight underestimate of Kt/V
during follow-up using baseline V is of the same magnitude
using either the equilibrated or non-equilibrated post-dialysis
samples; and (c) lower baseline albumin levels are associated
with a greater reduction in V over time.
The reduction in V after 1 year without any significant
change in body weight is the major and so far unpublished
finding. One possible reason for this could be the increasing
age of the patients during the follow-up, but the expected
reduction in V with age (0.31 l) is insufficient to explain the
observed reduction of 1.56 l. It is worth underlining the fact
that this considerable reduction in V over time was observed
in apparently clinically stable patients and, given the fact that
73% of lean body mass is body water, could have nutritional
importance. It can be estimated that our patients lost an
average of 2.1 kg of lean body mass (1.56 l divided by 0.73),
with an apparent loss of only 0.6 kg of total body mass.
The dietary advice given to our patients was to eat 1.2 g/
kg/day of proteins, and at least 35 kcal/kg/day. However, the
baseline protein catabolic rate was not a predictor of the
reduction in V during the follow-up, probably because it
depends not only on dietary protein intake but also on net
protein catabolism. This suggests that there may be a need for
more complete nutritional surveillance even in apparently
stable dialysis patients. Body weight is a result of the two
components of fat-free and fat mass: the first is obviously
related to urea distribution, but a reduction in V can be
associated with a constant body weight if there is a
concomitant increase in fat mass. Unfortunately, we did
not measure fat mass, but we can postulate a greater increase
than that physiologically observed in the elderly.
A true reduction in urea distribution volume over time
can therefore be interpreted as a clinically unfavorable
condition but, although this may be true for the dialysis
population as a whole, it is less reliable on an individual
patient basis because of the high intra-patient variability in
the kinetic calculation of V. In a study of 50 stable
hemodialysis patients, Kloppenburg et al.13 found that it
needs at least two or six V measurements to have a 95%
probability that the average of the observed values is,
respectively, within 20 and 10% error. Being aware of that,
and in an attempt to control this phenome non satisfactorily,
we made three kinetic evaluations of V in 1 week and then
averaged the three values for analysis. We also found
considerable variability in the reduction in urea distribution
volume after 1 year of follow-up, as shown by the high
standard deviation values.
The American and European guidelines,9,10 suggest
determining Kt/V monthly, thus making it necessary to
determine pre and post-dialysis urea concentration each
month in order to calculate V and Kt/V according to the
single-pool kinetic model. However, provided that V is
calculated accurately and its value does not change in stable
patients, ID provides an adequate estimate of dialyzer urea
clearance corrected for recirculation and can therefore be
used to calculate Kt/V at each dialysis session without the
need for blood samples or laboratory determinations. On the
basis of our results, given its variability, the practice of
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evaluating V once a month may not be satisfactory, and so a
good compromise could be to determine it less frequently but
repeatedly (e.g. three times every 6 months).
Using the single-pool, urea kinetic model and ID as
dialyzer urea clearance, we obtained higher eqV values than
non-eqV values: an absolute increase of 8% (from 47 to 55% of
end-dialysis body weight), and a relative increase of 17%.
This is expected because, in the urea kinetic model, the value
of V directly correlates with urea clearance, and inversely with
the magnitude of the dialysis decrease in plasma urea
concentrations.22 Given urea rebound,6 Ct300 was higher than
Ct1000, and the magnitude of the decrease in plasma urea
concentrations using Ct300 was less than that using Ct1000, with
a consequently greater value in eqV than in non-eqV. What is
important is that both eqV and non-eqV showed similar
variations over time in both absolute and relative terms, thus
suggesting that the change in V over time is method-
independent. However, assuming constant V values, the
reduction in V after 1 year had the average consequence of a
5% underestimate of true Kt/V (an absolute difference of 0.07
in both eqKt/V and spKt/V). As this is an underestimate and
not an overestimate, we can avoid the risk of under-dialysis
when the dialysis dose is estimated using baseline V values.
The reduction in ID after 1 year of follow-up was
unexpected, and could have been due to a decrease in the
blood water flow/blood flow ratio secondary to an increase in
hematocrit or total protein concentrations, or decreased
dialyzer efficiency. It must also be remembered that ID is
influenced by recirculation, and so a further explanation
could be an increase in total recirculation. Unfortunately, we
cannot verify these hypotheses because hematocrit values
were only recorded at baseline, and recirculation was not
determined. Finally, we can assume that a reduction in V
reduces ionic flux (and thus ID) as a result of small changes
in sodium plasma water during ID measurements.21
Finally, our results concerning the explored predictors of a
reduction in V over time underline the predictive role of
albumin levels not only in terms of morbidity and
mortality,22 but also in nutritional terms because high
albumin levels are associated with the better preservation of
baseline V over time and corroborate the hypothesis of urea
distribution volume as a nutritional index. On the other
hand, the inverse relationship between the change in V over
time and the baseline V values may be due to sub-clinical
overhydration at baseline and the effect of a regression to the
mean, although the three baseline evaluations of V should
have reduced the magnitude of this statistical phenomenon.
Finally, in our patients, albumin levels and total body water
values are not significantly related. At this regard, Dumler23
reported similar results when considering total body water
and a significant inverse relationship when considering
extracellular water content.
In conclusion, in terms of depuration, the underestimate
of Kt/V during follow-up using baseline V values suggests
that a kinetic V evaluation every year may be sufficient as the
risk of underestimating the dialysis dose can only lead to an
increase in the delivered dose. However, the considerable
reduction in V over time in apparently clinically stable
patients could be a nutritional index, and may suggest that, at
least in patients with low albumin levels, V should be more
frequently evaluated in order to detect a possible indolent
loss of lean body mass.
MATERIALS AND METHODS
Between February 1999 and April 2000, 52 clinically stable patients
on thrice-weekly bicarbonate dialysis were recruited in 13 Italian
dialysis centers. The entry criteria were an age of 18–80 years,
bicarbonate hemodialysis three times a week for at least 6 months
using two needles and a dialyzer of any type, and written consent to
participate. The exclusion criteria were residual renal function
41 ml/min/1.73 m2 or diuresis 4200 ml/day, single-needle hemo-
dialysis and an unstable clinical condition in the 3 months preceding
enrolment (e.g. myocardial infarction, vascular access thrombosis,
transient ischemic attack, clinically relevant infection including
sepsis).
It was planned that each patient would undergo a 1-year follow-
up. The enrolled patients were dialyzed using an Integra machine
equipped with the Diascan Module (Gambro-Dasco, Medolla, Italy),
which is capable of giving repeated measurements of ID during a
dialysis session. The first measurement was completed 10 min after
the start of the session, and the subsequent measurements were
made every 30 min. V was assessed during three consecutive dialysis
sessions at baseline and after 1 year using the single-pool, variable
volume urea kinetics model24 and the mean value of repeated
instantaneous determinations of ID. All of the input parameters
necessary to calculate V were determined at each session for 1 week.
The blood samples for plasma urea concentration analysis were
taken before the start (C0), at the end of the session with the blood
speed pump reduced a 100 ml/min for 10 s (Ct1000), and 30 min after
the end of the session (Ct300); Ct1000 and Ct300 were, respectively, used
to determine the non-equilibrated (non-eqV) and equilibrated urea
distribution V (eqV). The mean baseline values were used as
reference. Single-pool Kt/V (spKt/V) and equilibrated Kt/V (eqKt/V)
were also calculated.
The dialysis schedule (dialysis modality, dialyzer membrane,
filter surface, dialysate composition) during the study was left
unchanged from that used in the period before enrolment.
Sample size calculation
The sample size was calculated considering the difference in
baseline/1-year Kt/V as the main response variable: a variation of
10% with a standard deviation of 15%. The calculated sample size of
50 patients was based on a significance level (a error) of 0.05, a b
error of 0.05, a power (1b) of 0.95, a two-tailed paired t-test, and a
drop-out rate of 30%.
Statistical analysis
The descriptive analysis of the patients at baseline was based on the
mean values and standard deviations of normally distributed
continuous variables; the median values and inter-quartile ranges
of skewed continuous variables; and the counts and percentages of
categorical variables.
The changes in body weight, ID, V, Kt/V, the urea reduction ratio,
and the protein catabolic rate after 1 year were investigated using the
paired-sample t-test. A multiple linear regression model without
intercept was used to explore which of the following covariates and
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factors significantly related (Po0.05) to the change in V after 1 year:
age, gender, dialysis vintage, dialysis treatment time, baseline values of
V, urea reduction ratio, protein catabolic rate, hematocrit, C reactive
protein and albumin. Baseline V was included in the model in order
to take into account the possible regression to the mean due to
random error in the evaluation of the true V value at baseline in some
patients. R2 was calculated in order to measure how much of the
variability on the y-axis (change in V) was explained by the variation
in the predictors. The backward approach was used, and a probability
value of less than 0.05 was considered statistically significant.
The V values at baseline were plotted against the age of the
patients in order to explore how much of a reduction can be
expected after 1 year in relation to increased age.
All of the analyses were made using SPSS statistical software for
Windows, release 11.
Informed consent and ethical surveillance
Before starting the study, the patients were informed about its aims,
the expected benefits to them and/or others, the risks and
inconveniences involved, and their right to refuse to participate or
to withdraw from the study at any time without sanction. Their
written consent was obtained. The study was carried out in
accordance with the Declaration of Helsinki and its subsequent
modifications, and was approved by the Ethics Committees of the
participating centers.
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